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Abstract
Background: Motivational negative symptoms hinder quality of life and daily functioning of individuals with
schizophrenia spectrum disorders. A recently developed intervention, Switch, has shown promising effects on
negative symptoms and functional outcomes. Switch targets multiple cognitive, emotional and behavioural
processes associated with motivation and goal directed behaviours. We aimed to investigate its effects on
motivation and associated processes in a naturalistic setting, and to explore the dynamics between the processes.
Methods: We used a single case approach (n = 3), with a pre-post and follow-up assessment design, which also
included ambulatory assessments (experience sampling method, ESM; and step count). We computed autoregressive
lag 1 models to evaluate the effects of the intervention on daily motivation levels and related processes, descriptive
pie-charts, and vector autoregressive modelling to reveal the dynamics of the processes over time.
Results: The intervention was beneficial for each participant according to traditional evaluations of motivational
negative symptoms, apathy, daily functioning and quality of life. The effects on the ESM variables revealed distinct
outcomes for each individual. The dynamics between the various processes differed between participants, and
fluctuated within participants (when comparing baseline, intervention phase, and follow-up).
Conclusions: This study used an innovative approach to look at the effectiveness of an intervention. The intervention
seems to lead to meaningful improvements in motivational negative symptoms and functional outcomes. The
mechanisms of change need to be further investigated.
Trial registration number: ClinicalTrials.gov, NCT04325100. Registered 27 March 27, 2020 -retrospectively registered.
Reporting: Guidelines from the Transparent Reporting of Evaluations with Non-randomized Designs (TREND)
statement were followed.
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Background
Negative symptoms are highly prevalent in individuals with
schizophrenia [1]. These symptoms are generally under-
stood as comprising two factors: expressive deficits, includ-
ing blunted affect and alogia; and motivational or
experiential deficits, including anhedonia, avolition, and aso-
ciality [2, 3]. Motivational negative symptoms appear to be
the main obstacle to daily functioning [4, 5] and quality of
life [6]. To date, psychological interventions as well as
pharmacological treatments have shown limited or incon-
sistent effects on negative symptoms [7, 8]. One way of rem-
edying this is to better understand the underlying processes
of motivation in schizophrenia in order to provide tailor-
made interventions that focus on those particular processes.
In a previous study [9], we presented a model of mo-
tivation in schizophrenia that integrates various emo-
tional/hedonic, (neuro) cognitive and behavioural
processes that are related to motivation and goal-
directed behaviours and that are often dysfunctional in
individuals with schizophrenia. This model was predom-
inantly inspired by the model developed by Kring and
Barch, which follows the course of hedonic processes,
from the anticipation of a reward to its obtainment [10].
The model we describe here integrates additional pro-
cesses (e.g., dysfunctional attitudes) and furthermore is
multilevel. Figure 1 presents this three-level model. The
first two levels are at the foundation of the model and
include personal values and goals on the first level, and
self-esteem on the second level. The third level narrows
in on a chosen value or goal, and targets those processes
that underpin motivation. It starts with the anticipation
of pleasure, which is mainly sensory. The next step is
largely cognitive and requires an estimation of the effort,
the value and the probability of attainment of the chosen
goal. These processes can be influenced by dysfunctional
attitudes (e.g., defeatist beliefs or low self-efficacy) and
thus potentially altering the decision to take action.
Once the motivated decision has been taken, planning
skills come into play, as well as action initiation abilities.
In-the-moment enjoyment occurs while advancing to-
wards or reaching the chosen goal. Finally, the experi-
ence of successfully moving towards one’s goal can be
Fig. 1 Three-level model of motivation (reproduced with permission from [9])
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recalled (reminiscence) and can feed further anticipation
(for a more detailed description and an illustration, see
[9]).
We developed an intervention, Switch, that targets the
multiple elements and processes identified in the afore-
mentioned model [9], using various strategies that have
proven to be beneficial as delivered separately or in
other clinical populations (e.g., [11–16]). A pilot study
was conducted with 8 participants with schizophrenia
spectrum disorders who followed Switch for a year (30
sessions on average). We found significant moderate to
large positive effects on motivational negative symptoms
and functional outcomes. The novelty of the Switch
intervention is that it is specifically designed to address
motivational negative symptoms and therefore the mul-
tiple and various processes related to these symptoms.
The strength of Switch is also its recovery approach
[17], with a focus on autonomy and personal resources,
goals, and values.
In the current study, we wished to further validate
Switch, however, using a different set-up by providing the
intervention twice a week for 2 months, in order to meet
certain time constraints of psychiatric health care. Add-
itionally, we aimed to better understand the dynamics of
processes related to motivation across time. In order to do
this, we used a single case design which allows a thorough
investigation of mechanisms of change by applying re-
peated measurements of the processes of interest [18].
The high internal validity of this approach can even fur-
ther improve by including intensive repeated assessment,
such as the Experience Sampling Method (ESM [19, 20];)
or other ambulatory assessment strategies that imply con-
tinuous and objective measurement of activity [21, 22].
Such intensive repeated assessment can help understand
the dynamic interconnections between the variables of
interest over time. Furthermore, ESM diminishes the risk
of retrospective recall biases, and allows a more natural
and nuanced evaluation of emotions, cognitions and be-
haviours in everyday life and in the person’s real environ-
ment (vs. laboratory and clinical settings) [22].
The first aim of this study was to evaluate the effect-
iveness of a shorter version of the Switch intervention in
individuals with schizophrenia and schizoaffective dis-
order provided in a naturalistic setting. We expected (1)
an improvement on motivation/apathy, quality of life
and functional outcomes (primary outcomes), after the
intervention and/or at follow-up; (2) an improvement on
the various cognitive, emotional and behavioural pro-
cesses identified in our model and targeted in the inter-
vention (ESM variables), during the intervention and/or
at follow-up; (3) an increase in step count as this has
been shown to be an objective proxy measure of nega-
tive symptoms [23], during the intervention and/or at
follow-up. Second, we aimed to explore the dynamics of
the processes associated with motivation (ESM variables)




Participants were recruited in March 2019, via referral
from a mental health community centre in the French
speaking community of Belgium, where the recruitment,
assessments and intervention took place. Inclusion cri-
teria for the present study were: aged between 18 and
65, met DSM-5 criteria for schizophrenia or schizoaffec-
tive disorder [24] and a good understanding of French.
Exclusion criteria were: presented an unstable clinical
picture (i.e., no acute positive symptoms); evidence of a
significant change in medication within 1 month prior
to baseline assessment; history of severe brain trauma or
epilepsy; comorbid intellectual disability; and moderate
or severe substance use disorder other than tobacco (ac-
cording to the DSM-5; i.e., showing 4 or more symp-
toms). The head psychiatrist from the mental health
community centre was familiar with the inclusion and
exclusion criteria of the study and other relevant details
(e.g., the need for participants to provide informed con-
sent). Thereafter, out of a pool of 60 patients, six candi-
dates who fulfilled the criteria were contacted,
introduced to the study and asked if they accepted to be
contacted by the main investigator. Three accepted.
Next, the main investigator contacted these three candi-
dates by phone and presented the study. The partici-
pants were then seen in person and received a thorough
explanation of the evaluation protocol, the intervention
and their rights as participants in the study. They were
invited to read the information sheet (including repeti-
tive disclosure and emphasis of key points, as recom-
mended by [25]), ask any questions that they might
have, and sign the informed consent if they accepted to
participate. Three participants enrolled in the study and
were assigned to the Switch intervention in April 2019.
One participant was lost to follow-up in October 2019.
The study was approved by the Liege University Hos-
pital Ethics Committee (B707201629105). Sociodemo-
graphic and clinical characteristics of the participants
are reported in Table 1.
Study design and procedure
Participants underwent three types of evaluation: trad-
itional assessment scales of motivational deficits, apathy,
quality of life and daily functioning; ambulatory assess-
ment including ESM (i.e., questionnaires); actigraphy
(step count). Participants were evaluated on the trad-
itional assessment scales before the intervention (Pre),
after the 2-months intervention (Post), and 3-months
after the end of the intervention (Follow-up). ESM and
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actigraphy were used before (T0), during (T1), and after
the intervention (T2), as well as at follow-up (T3). Fig-
ure 2 provides a visualisation of the study design and
procedure. Participants received feedback on all evalua-
tions at the end of the study.
Traditional evaluation (primary outcomes)
Assessments were completed by trained evaluators. Par-
ticipants were told to refer to the last 2 weeks when
completing the following scales:
Brief Negative Symptoms Scale (BNSS) [27]. The
French version of the BNSS was used in this study [28].
The BNSS assesses expressive and motivational negative
symptoms. Only the BNSS – Motivation subscale was
used, which is the mean of the following subscales: an-
hedonia (intensity of pleasure during activities, frequency
of pleasure, intensity of expected pleasure from future
activities), asociality (behaviour, internal experience),
avolition (behaviour, internal experience). Each item is
scored from 0 to 6 (0 = no impairment; 1 = very slight;
2 =mild; 3 =moderate; 4 = moderately severe; 5 =
marked; 6 = severe). A blinding procedure was used: par-
ticipants’ interviews were recorded and each video or
sound recording was evaluated at the end of the study
by two independent evaluators who were unaware of the
recordings’ assessment time. The BNSS possesses excel-
lent internal, convergent and discriminant validity [28],
excellent test-retest and interrater reliability [27], and
good sensitivity to change [29].
Lille Apathy Rating Scale – Patient version (LARS-p)
[30]. The LARS is a semi-structured interview that eval-
uates the different dimensions (cognitive, emotional and
behavioural) of apathy through the following subscales:
everyday productivity, interests, taking initiatives, novelty
seeking, voluntary actions, emotional responses, concern,
social life and self-awareness. The total score ranges
from − 36 to 36 ([− 36; − 22] = absence of apathy; [− 21;
− 17] = tendency towards apathy; [− 16; − 10] =moderate
apathy; [− 9; 36] = severe apathy). The LARS-p possesses
a high level of inter-rater reliability and satisfactory in-
ternal consistency [31].
Schizophrenia - Quality of Life questionnaire (S-QoL)
[32]. The S-QoL is a 41-item questionnaire that evaluates
life satisfaction regarding psychological wellbeing, self-
esteem, family relationships, relationships with friends, re-
silience, physical wellbeing, autonomy and sentimental
life. Items are rated on a 5-point Likert scale (1 =much
less satisfied than expected; 2 = less satisfied; 3 = slightly
less satisfied; 4 = as satisfied; 5 =more satisfied). The total
score ranges from 0 to 100, higher scores indicating better
subjective quality of life. The S-QoL shows good internal
and convergent validity, excellent test-retest reliability
[32], and good sensitivity to change [33].
Informants were interviewed to provide an external un-
derstanding regarding participants functioning. The in-
formant for participant 2i-1 was her husband; the
informant for participant 2i-2 was the head of his super-
vised housing; participant 2i-4 did not wish to involve an
informant. Informants completed the following two scales:
Lille Apathy Rating Scale – Informant version (LARS-i) [34]
(see the patient version for a description). The LARS-i shows
high internal consistency and concurrent validity, as well as
high levels of test-retest and inter-rater reliability [34].
Functional Remission of General Schizophrenia (FROGS)
[35]. The FROGS is a measure of daily life outcomes,
which evaluates level of functioning in 5 different do-
mains: daily life, activities, relationships, quality of adapta-
tion, and health and treatment. Via a semi-structured
interview with the informant, each item is assessed on a 5-
point scale: 1 = does not do; 2 = does partially; 3 = does a
significant part; 4 = does almost all of it; 5 = does perfectly.
The total score ranges from 19 to 95. The threshold score
for remission is 61 [36]. The FROGS possesses high con-
current validity and internal consistency [35].
Table 1 Sociodemographic characteristics
Individual 2i-1 2i-2 2i-4
Age 29 34 39
Gender Female Male Female
Diagnosis SZ SZ SZ
Illness duration (years) 10 10 7
Education (year) 10 12 14
Living Conditions With partner Supervised housing With family
Work / / /
Switch (number of sessions + booster
session)
12 + 1 15 + 1 10 + 0
Medication / dose / CPZeq Aripiprazole / 2.5 mg/day / 50
mg
Aripiprazole / 200 mg/month / 142.86
mg
Olanzapine / 350 mg/3
months /
277.47 mg
CPZeq Chlorpromazine equivalents (mg/day) [26]
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Ambulatory assessment (secondary outcomes)
ESM questionnaire
Prior to the start of the study, the participants received ex-
tensive explanations regarding the ESM procedure. Partici-
pants installed the MetricWire app (https://metricwire.com/
) and were logged in with a sham email address. Participants
filled in an example-questionnaire with the investigator who
explained all the questions and their possible answers.
For the 14 consecutive days of the baseline phase, par-
ticipants were prompted by the app MetricWire five
times a day at pseudo-random time points, within 3-h
time frames between 7.30 a.m. and 10.30 p.m. Each
prompt invited the participant to open the app and an-
swer the questionnaire referring to what he/she was ex-
periencing just before the prompt. The participants had
20min to fill in the questionnaire and they received a re-
minder after 10 and 15min. During the 2 months of
intervention, in order to reduce the burden on the par-
ticipants, the number of prompts was reduced to three
per day, within 5-h time frames. After the end of the
intervention, participants were prompted again 5 times
per day for another 2 weeks. As participants did not
complete enough questionnaires after the end of the
intervention, the post-assessment ESM observations
(T2) were not taken into consideration.
Table 2 presents the ESM questionnaire that was de-
veloped based on the different variables included in the
motivation model described in the introduction. It was
created following guidelines from Kimhy et al. [37]. The
questionnaire included 14 questions, plus three optional
branched questions, i.e., determined by the participant’s
answer to a previous question.
The categorical ESM outcomes of interest were: activity’s
meaning, motivation, mood, confidence, and savouring.
Activity’s meaning, effort, energy, mood, and confidence
represent each a single item from the ESM questionnaire.
Motivation is a composite measure of the items motivation
and wanting to give up (reverse coded). Savouring is a
composite measure of present enjoyment, reminiscence,
and projection into the future.
Nominal ESM outcomes of interest were coping strat-
egies (in the presence of discouraging beliefs), social con-
tact, activity and initiation. For further details and label
descriptions of the ESM measures, please refer to Table 2.
Step count
Participants were provided with an activity band
(MiBand 3, Xiaomi) which they had to wear at all times
(day and night) during the different phases of the study
(baseline, intervention, post-measurement, and follow-
up). The band is waterproof and has a battery autonomy
of approximately 20 days. A MiFit sham account was
created in order to synchronize the activity band with
the app on the participant’s smartphone. The MiFit app
provided the total amount of steps per day.
Intervention
Switch was delivered by the main investigator, a trained
psychologist and psychotherapist. The individual ses-
sions lasted 1 h and were given twice per week for 2
months, in the participants’ local mental health centre.
The first sessions were dedicated to building a thera-
peutic alliance, getting to know the person and identify-
ing personal resources, goals and values (i.e., addressing
the first two levels of the motivation model, see 1. Intro-
duction). Strategies were then taught in order to help
the person to engage in behaviours directed towards
these chosen goals and values (i.e., moving to the third
level of the model). Multisensory “imagery” was used to
help to look forward to the future (i.e., pleasure anticipa-
tion). This type of projection into future actions/goals
included not only visualising the scene (i.e., the person
her/himself, the context, the actions), but also imagining
the possible sounds, physical sensations, smells, flavours,
pleasant emotions, constructive thoughts, etc. The imagery
thus goes through the different senses, in order to increase
Fig. 2 Design of the study and assessment procedure. BNSS = Brief Negative Symptom Scale; LARS = Lille Apathy Rating Scale patient and
informant; FROGS = Functional Remission of General Schizophrenia, S-QoL = Schizophrenia Quality of Life questionnaire
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the possibility of experiencing pleasure and to help identify
what modality generates the more pleasure – and conse-
quently that has the higher motivational power. The im-
agery could focus on the process (e.g., baking a cake) or the
result (e.g., eating the cake). A restructured decisional bal-
ance tool was used to address the effort-value computation.
The “motivation’s switch”, as can be seen in Fig. 3, was used
to identify all the reasons why the person would not engage
in a certain activity (including potentially discouraging
thoughts, required effort), and all the good reasons why
she/he would engage in that activity. Additionally, a column
was used to indicate quick solutions for the smaller obsta-
cles that were identified. The solutions and pros represent
the “ON” part of the switch, which is highlighted relative to
the cons’ column, which represents the “OFF” part of the
switch. The cons column potentially included obstacles and
dysfunctional attitudes that needed further attention. Par-
ticipants were then guided in solution-seeking strategies.
Furthermore, significant discouraging thoughts and low
self-efficacy were challenged using cognitive restructuring
(e.g., generating more constructive thoughts) and/or a cog-
nitive defusion approach (e.g., using metaphors, training
mindfulness). Help in planning and initiation strategies
(electronic reminders, implementation intention, post-its
…) addressed the subsequent steps in the model. Finally,
participants were invited to use various reminiscence strat-
egies (e.g., sharing of experience with others, keeping a
diary, looking at photos, buying souvenirs) to increase posi-
tive memories and boost motivation for new actions or
goals to engage in.
Each participant learnt the different strategies in rela-
tion to their individual goals and needs. A folder which
presented the rationale for each strategy was given to
the participants. Take-home assignments were given and
stored in the same folder. Participants were also given small
cards (that could fit in their wallet) containing the key
Table 2 ESM Questionnaire
Variables Questions Rating
Mood I feel … 1–7 Likert; 1 = Unhappy; 4 = Neutral; 7 = Happy
Discouraging
beliefs
Discouraging thoughts are crossing my mind. 1–7 Likert; 1 = Not at all true; 7 = Totally true
Coping (only if
Q3 > 4).
How am I dealing with these thoughts? I’m not. / I’m distancing myself from them. / I’m trying to use more
constructive thoughts. / I’m looking for concrete solutions. / Other:
Coping (other) You indicated “other”. What precisely do you do to deal
with these discouraging thoughts?
Free text
Confidence I feel confident. 1–7 Likert; 1 = Not at all true; 7 = Totally true
Motivation I feel motivated. 1–7 Likert; 1 = Not at all true; 7 = Totally true
Energy I have energy. 1–7 Likert; 1 = Not at all true; 7 = Totally true
Social Who am I with? Stranger(s), other / Acquaintance(s) / Colleague(s) / Friend(s) / Family /
Partner / I’m alone
Activity What am I doing? Nothing / Rest, passive activity (TV, internet, reading...) / Transport / Hygiene,
household, grocery, meal / Social activity/interaction / Leisure / Physical
activity / Work, study, training, attending a workshop / Other
Activity (other) Specify your activity: Free text
Initiation Select the option that best corresponds with your
situation:
I am the one who spontaneously started this activity. / Someone else
encouraged me to start this activity. / I am not doing anything in particular.
Present
enjoyment
I feel some pleasure in what I am doing. 1–7 Likert; 1 = Not at all true; 7 = Totally true
Wanting to
give up




This activity is important to me. 1–7 Likert; 1 = Not at all true; 7 = Totally true
Effort This activity requires some effort. 1–7 Likert; 1 = Not at all true; 7 = Totally true
Reminiscence Since the last prompt, I have been recalling pleasant
past events.
1–7 Likert; 1 = Not at all, I have been thinking of unpleasant events; 4 = I
have not been particularly thinking about the past; 7 = Absolutely, I have
been thinking a lot about pleasant past events.
Projection into
the future
Since the last prompt, I have been looking forward to
some activities or events.
1–7 Likert; 1 = Not at all, I have been apprehending the future; 4 = I have not
been particularly thinking about the future; 7 = Absolutely, I have been
greatly looking forward to the future.
Note: Items have been translated from French into English.
Italics: conditional questions (branching).
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elements of each strategy. Furthermore, during the last 3
weeks of the intervention, the participants received daily
triggers (via the MetricWire app) inviting them to look for-
ward to coming events/activities (morning trigger) and to
look back at their day and reminisce about positive inci-
dents (evening trigger). The morning trigger included an
mp3 that could be listened to from the app and that pro-
vided a guided multi-sensory projection into the future. Fi-
nally, a booster session took place around 45 days after the
end of the intervention, consisting mainly of a reminder of
the different strategies and a troubleshooting of possible
obstacles.
The complete manual for the Switch intervention and
the participant booklet (both in French) can be re-
quested from the first author.
Analyses
Aim 1: treatment effects of switch on motivation and
related processes
We used effect size coefficients to report changes in
BNSS, LARS-p, LARS-i, FROGS and S-QoL scores. We
created effect size coefficients for the composite scores of
motivation/apathy and of QoL/functioning. Motivation/
apathy represented the mean of four scores from the
BNSS-Motivation (i.e., two scores from the two blinded
evaluators), the LARS-p and LARS-i. QoL/functioning in-
cluded the two scores from the S-QoL and the FROGS.
First, all variables were rescaled to fit a 7-point Likert-
scale (0 to 6) in order to have comparable scores amongst
the different scales and to compute effect sizes. The fol-
lowing equation was used to calculate the Cohen’s d
statistics effect size coefficient: X0 − X1Spooled , where Spooled
equals
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðn0 − 1ÞðSD0Þ2þðn1 − 1ÞðSD1Þ2
p
n0þn1 − 2 , where n represents the
number of observations (i.e. 4 observations for Motiv-
ation/Apathy, and 2 observations for QoL/functioning)
and SD the within-person standard deviation. This coeffi-
cient thus takes into account the number of observations
and the standard deviation within each phase (pre and
post, or pre and follow-up) and within each participant.
To further investigate the effects of the intervention, we
examined whether Switch had an effect on the ESM vari-
ables during the intervention and at follow-up. In a first
step, we calculated the means and standard deviations per
phase. Additionally, we performed unequal variances t-tests
and computed the Cohen’s d statistics (with pooled stand-
ard deviation as the denominator) to estimate effect sizes.
In a second step, we fitted eight separate autoregressive lag
1 (AR (1)) models using the lm function in R (version
3.6.1). Dependent variables were the outcomes of interest,
whereas independent variables were the lag of the
dependent variables and the intervention phase, thus repre-
senting the autoregressive parameter and the mean inter-
vention effect for each intervention phase respectively.
Given that the AR (1) model assumes identical distribution
of the errors throughout time, we lagged the independent
variable within day and phase, resulting in a missing value
for the lag at the first prompt of the day, as well as at the
first prompt of a new phase. After each model, we per-
formed a test for homoscedasticity after removing outliers,
using the outlierTest function of the car package in R. In
Fig. 3 The motivation’s switch. Updated version of the decisional balance
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case residuals appeared to be heteroscedastic, the ini-
tial model (with outliers) was refitted using robust
standard errors, by defining the robust variance-
covariance matrix as argument using the function
vcov of the stats package in R. For the analyses in
both steps (t-tests, Cohen’s d, and AR (1) models),
baseline scores were taken as the reference group. Fi-
nally, we investigated – in descriptive pie charts –
how nominal ESM variables evolved throughout the
intervention. All analyses were performed for each
participant individually.
Aim 2: dynamics between motivation and related processes
To explore the dynamics of the processes associated
with motivation, we used individual network represen-
tations based on vector autoregressive (VAR) model-
ling. We computed network models for each phase
separately (baseline, intervention and follow-up). We
used the graphicalVAR package ver. 0.2.2 [38] to esti-
mate the temporal and contemporaneous models and
to obtain a visual representation using the qgraph
package ver. 1.6.4 [39]. The nodes in the networks
represent the variables, whereas the edges (i.e., the
lines) represent the associations between the variables.
In the temporal network, the edges are directed and
indicate which variable predicts other variables in the
next timepoint. In the contemporaneous network, the
edges represent partial correlations between the vari-
ables, after controlling for all the other variables in
the same timepoint and also in the previous time-
point. All associations reported and represented on
the models are significant (p < .05).
We also calculated plots representing rolling means
(or “moving averages”) which can be found in supple-
mentary material, Figure S1. The course of the different
processes – during baseline, intervention and at follow-
up – was plotted using the rollapply function from the
emaph package ver. 1.0.0 [40]. This provides rolling
means, i.e., the means of each variable as it progresses
over time. A rolling mean smooths the time-series, thus
making it easier to detect any evolution (e.g., trend and
periodicity) and to reveal any associations between
variables.
Results
Detailed descriptions of (1) the effects of Switch on mo-
tivation and related processes and (2) their dynamics are
presented below for each participant individually. Results
on the traditional assessment scales (BNSS, LARS,
FROGS, S-QoL) are presented for each participant in
Table 3.
Participant 2i-1
Aim 1: treatment effects of switch on motivation and
related processes
At baseline, participant 2i-1, a 29-year-old female, pre-
sented with mild motivational negative symptoms ac-
cording to the BNSS, and no apathy according to the
LARS. She was not assessed directly at post-
measurement, potentially due to a relapse which she re-
ported later. However, her scores at follow-up showed
that motivational deficits reduced to a minimal level ac-
cording to the BNSS. The score at the LARS-i also re-
duced. Overall, we observed a medium to large effect
size coefficient for the motivation/apathy composite
score at follow-up. Participant 2i-1 also reported a
slightly higher quality of life. The FROGS score revealed
a considerate increase in functioning. Overall, we ob-
served a small to medium effect size coefficient for the
QoL/functioning composite score at follow-up.
The effects on the ESM variables for participant 2i-1
are presented in Table 4. During the intervention phase,
our analyses showed a significant increase in effort (t
(df) = 3.69(101); p < .001; d = .64), and a significant effect
of the intervention on this score (b = .82, p = .029). En-
ergy (t (df) = 2.28(113); p = .025; d = .42), mood (t (df) =
4.87(97); p < .001; d = .85), confidence (t (df) = 3.44(98);
p < .001; d = .60), and savouring (t (df) = 2.91(106); p =
.004; d = .52) scores were significantly better. Further,
there was a significant intervention effect for mood (b =
1.19, p < .001), confidence (b = 0.64, p = .008), and sa-
vouring (b = 0.44, p = .025).
Based on the pie-charts that are presented in Fig. 4, it
appears that participant 2i-1’s discouraging beliefs de-
creased during the intervention and at follow-up. Further,
when experiencing discouraging beliefs, she appeared to
cope better during the intervention and at follow-up. The
occurrences of “no coping” indeed decreased. Finally, she
appeared to use a more varied set of coping strategies,
namely, she started using cognitive restructuring strategies
during the intervention and she increased their use at
follow-up. Regarding social contact, at baseline, partici-
pant 2i-1 spent most of her time in the company of other
people (varying from strangers to relatives). During the
intervention and at follow-up, she seemed to spend even
more time in the company of other people. Regarding ac-
tivities, participant 2i-1 reported that most of the time she
was resting or doing a passive activity and, next in line, re-
ported activities related to household chores. During the
intervention, the proportion of passive activity decreased
in favour of more social and leisure activities. This was
not observed at follow-up. Finally, at baseline, participant
2i-1 was rarely not doing anything in particular and only
occasionally needed someone to encourage her to engage
in a certain activity. She showed even more self-initiation
during the intervention and at follow-up.
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Aim 2: dynamics between motivation and related processes
Based on the network analyses that are presented in Fig. 5,
it appears that during the baseline phase, participant 2i-1’s
discouraging beliefs were significantly auto-correlated
(r = .31; see the autoregressive loop in the Baseline Tem-
poral model). This indicates that the more she had dis-
couraging beliefs, the more she would have discouraging
beliefs also at the next time of measurement. These dis-
couraging beliefs appeared to co-occur with lower mood
(r = .26) (see Baseline Contemporaneous model) and ap-
peared to impact subsequent levels of energy (r = −.17),
feelings of confidence (r = −.18) and savouring processes
(r = −.15) (see Baseline Temporal model). During the
intervention, these associations decreased. Indeed, dis-
couraging beliefs were no longer significantly autocorre-
lated, and were only slightly and negatively associated
with subsequent savouring processes (r = −.09) (see Inter-
vention Temporal model). This was mostly maintained at
follow-up. At follow-up, motivation was shown to be
significantly associated with the activity’s meaning, i.e., the
more she was motivated, the more meaningful was the ac-
tivity she was engaged in (r = .16). Furthermore, both mo-
tivation and activity’s meaning became predictive of
engagement in later effortful activities (r = .30 and r = .17,
respectively, see Follow-up Temporal model).
Participant 2i-2
Aim 1: treatment effects of switch on motivation and
related processes
At baseline, participant 2i-2, a 34-year-old male, pre-
sented with moderate to moderately severe motivational
negative symptoms according to the BNSS, and moder-
ate apathy according to the LARS. At post-
measurement, motivational deficits were evaluated as be-
ing mild, and apathy scores, both LARS-i and LARS-p,
decreased. Overall, we observed a very large effect size
coefficient for the motivation/apathy composite score at
post-measurement. There was no improvement on qual-
ity of life. The FROGS score revealed a considerate in-
crease in functioning. Overall, we observed a very large
effect size coefficient for the QoL/functioning composite
score at post-measurement.
At follow-up, the improvement on the BNSS and the
LARS-p was no longer observed. However, the apathy
score according to the participant’s informant (LARS-i)
reduced, reaching the threshold for “no apathy”. Overall,
there was no significant change for the motivation/ap-
athy composite score at follow-up. Participant 2i-2 re-
ported higher scores on quality of life (S-QoL). The
FROGS score revealed further improvement in func-
tioning. Overall, there was a very large effect size co-
efficient for the motivation/apathy composite score at
follow-up.
The effects on the ESM variables for participant 2i-2
are presented in Table 4. During the intervention phase,
his mood significantly worsened (t (df) = − 2.77(85); p =
.007; d = .86), as well as savouring (t (df) = − 3.65(83);
p < .001; d = .65). There was a significant intervention ef-
fect for mood worsening (b = −.41; p = .09), but not for
savouring (b = −.24; p = .12).
At follow-up, participant 2i-2 engaged in significantly
more effortful activities (t (df) = 3.27(68); p = .002; d =
.76). There was, however, no significant intervention ef-
fect for effort (b = .76; p = .23).
Based on the pie-charts that are presented in Fig. 6,
it appears that participant 2i-2 experienced more dis-
couraging thoughts during the course of the interven-
tion and at follow-up. He also reported more
occurrences of not coping with these thoughts. Re-
garding social contact, he appeared to be alone most
of the time, which did not change during the inter-
vention or at follow-up. Regarding activities, there is
no apparent change from baseline to the intervention
Table 3 Pre, post and follow-up scores on the traditional












2i-1 BNSS-Mota 1.79 1.07
LARS-i −27 −32
LARS-p −23 −18
Motivation/Apathy 1.35 0.99 0.73
S-QoL 66.34 71.70
FROGS 70 86
QoL/Functioning 3.75 4.58 0.37
2i-2 BNSS-Mota 3.43 2.29 3.5
LARS-i −11 −15 −23
LARS-p −17 −21 − 16
Motivation/Apathy 2.63 1.89 2.43 1.40 0.15
S-QoL 62.93 61.46 65.37
FROGS 64 72 77
QoL/Functioning 3.39 3.65 3.99 2.37 1.54
2i-4 BNSS-Mot 4a 3.14b
LARS-p 8 −14
Motivation/Apathy 3.89 2.49 4.34
S-QoL 35.12
FROGS 46 60
Note: BNSS-Mot Brief Negative Symptom Scale – Motivation (mean score); LARS
Lille Apathy Rating Scale informant (i) and patient (p) (total scores); FROGS
Functional Remission of General Schizophrenia (total score); S-QoL
Schizophrenia Quality of Life (total score); italics composite variables; bold
large effect sizes; ES effect size; maximum likelihood estimator, using pooled
standard deviation as the denominator
a BNSS Motivation average score of the two blinded evaluators
b Participant 2i-4 was not filmed at T2. The BNSS Motivation was scored by
one independent evaluator unaware of her score at baseline
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Table 4 Descriptive statistics regarding the different outcomes at baseline, during the intervention and at follow-up; Cohen’s d
coefficients; AR (1) models b coefficients
Participant 2i-1
Mean SD t df d CI lower CI upper b
Activity’s T0 5.13 1.64
meaning T1 5.53 1.24 1.66* 110 0.28 −0.04 0.60 0.32
T3 5.06 1.46 − 0.23 112 −0.04 − 0.41 0.33 − 0.23
Motivation T0 4.77 1.34
T1 4.57 1.33 −0.92 135 −0.15 − 0.47 0.17 0.24
T3 4.84 1.17 0.30 112 0.05 −0.32 0.43 0.21
Effort T0 4.44 2.13
T1 5.56 1.43 3.69**** 101 0.64 0.32 0.97 0.82**
T3 3.98 2.40 −1.07 101 −0.20 −0.58 0.17 −0.74
Energy T0 4.48 1.53
T1 4.82 1.20 1.48 113 0.25 −0.07 0.57 0.39
T3 5.08 1.26 2.28** 113 0.42 0.04 0.79 0.46
Mood T0 5.13 1.73
T1 4.55 1.97 −1.95* 146 −0.31 −0.63 0.01 −0.39
T3 6.33 0.86 4.87**** 97 0.85 0.47 1.24 1.19****
Confidence T0 5.08 1.38
T1 4.74 1.31 −1.56 130 −0.26 −0.58 0.07 −0.08
T3 5.76 0.71 3.44**** 98 0.60 0.22 0.98 0.64***
Savouring T0 4.29 1.12
T1 4.53 1.02 1.41 127 0.23 −0.09 0.55 0.40*
T3 4.78 0.67 2.91*** 106 0.52 0.14 0.90 0.44**
Steps T0 4949 1800
T1 3846 2492 −1.91* 36 −0.47 −1.06 0.11 − 616.78
T3 3926 1699 −1.65 30 −0.58 −1.32 0.15 − 755.84
Participant 2i-2
Mean SD t df d CI lower CI upper b
Activity’s T0 4.50 1.70
meaning T1 4.30 1.72 −0.65 78 −0.12 −0.48 0.25 −0.3966
T3 4.57 1.48 0.18 67 0.04 −0.44 0.52 −0.02
Motivation T0 4.57 0.82
T1 4.32 0.74 −1.73* 71 −0.33 −0.70 0.03 −0.26*
T3 4.30 0.64 −1.57 69 −0.36 −0.84 0.12 −0.30
Effort T0 2.76 2.03
T1 3.04 1.91 0.76 73 0.14 −0.22 0.51 0.28
T3 4.20 1.69 3.27*** 68 0.76 0.26 1.25 0.76
Energy T0 4.50 1.21
T1 4.22 0.94 −1.31 63 −0.27 −0.63 0.10 −0.34
T3 4.77 0.43 1.31 54 0.27 −0.20 0.75 0.17
Mood T0 4.00 0.91
T1 3.52 1.00 −2.77*** 85 −0.49 −0.86 −0.12 −0.41*
T3 3.87 1.14 −0.53 54 −0.13 −0.61 0.35 −0.10
Confidence T0 4.31 0.90
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phase. At follow-up, participant 2i-2 reported less
passive activity and more daily life tasks and social in-
teractions. Finally, regarding initiation, participant 2i-2
reported less often doing nothing in particular, espe-
cially at follow-up. Moreover, he reported slightly less
occurrences where someone needed to encourage him
to engage in a certain activity.
Aim 2: dynamics between motivation and related processes
Based on the network analyses that are presented in
Fig. 7, it appears that certain associations between the
different variables persisted over the course of the inter-
vention and at follow-up. Namely, savouring processes
were associated with mood at baseline (r = .19), even
more so during the intervention (r = .36) and at follow-
Table 4 Descriptive statistics regarding the different outcomes at baseline, during the intervention and at follow-up; Cohen’s d
coefficients; AR (1) models b coefficients (Continued)
Participant 2i-1
Mean SD t df d CI lower CI upper b
T1 4.52 0.84 1.30 73 0.25 −0.12 0.61 −0.01
T3 4.40 0.77 0.46 68 0.11 −0.37 0.58 −0.25
Savouring T0 4.24 0.54
T1 3.86 0.59 −3.65**** 83 −0.65 −1.03 −0.28 −0.24
T3 4.16 0.62 −0.43 58 −0.14 −0.62 0.33 −0.06
Steps T0 10,904 7518
T1 11,167 6397 0.13 21 0.04 −0.52 0.60 1129
T3 12,959 9407 0.62 21 0.25 −0.54 1.03 3488
Participant 2i-4
Mean SD t df d CI lower CI upper b
Activity’s T0 3.39 1.97
meaning T1 4.22 1.12 2.36** 51 0.55 0.14 0.96 0.92*
T3
Motivation T0 4.04 1.19
T1 3.81 0.91 −1.03 62 −0.23 −0.63 0.18 0.09
T3
Effort T0 3.61 1.76
T1 4.37 1.34 2.31** 62 0.51 0.09 0.92 0.43
T3
Energy T0 3.21 1.28
T1 3.57 1.12 1.44 70 0.30 −0.10 0.71 0.34
T3
Mood T0 1.79 1.28
T1 1.78 0.86 −0.02 57 0.00 −0.41 0.40 0.35
T3
Confidence T0 3.61 1.03
T1 3.48 0.95 −0.63 73 −0.13 −0.54 0.27 0.02
T3
Savouring T0 2.20 1.03
T1 2.30 0.78 0.52 62 0.11 −0.29 0.52 0.45*
T3
Steps T0 1819 1303
T1 4267 2800 2.71** 13 1.20 0.33 2.07 2270*
T3
Significance levels: * p < .10; ** p < .05; *** p < .01; **** p < .001
Notes. SD standard deviation; t t-value for difference in mean between T0-T1 and T0-T3; df degrees of freedom; d Cohen’s d; CI confidence intervals of the d
coefficient; b AR (1) model’s b coefficient (General Least Squares); T0 baseline; T1 intervention; T3 follow-up of 3 months
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Fig. 4 Pie charts for nominal variables of participant 2i-1
Thonon et al. BMC Psychiatry          (2020) 20:464 Page 12 of 22
Fig. 5 Network models of participant 2i-1. Positive associations appear in green (continuous lines) and negative associations appear in red
(dashed lines). The stronger the relationships, the thicker the edges. Only associations with p-values < .05 are plotted. For a colour version of this
figure, see the digital version of the paper
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up (r = .21). Furthermore, engaging in meaningful activ-
ities were associated with more effort at baseline (r = .23)
and during the intervention (r = .33), but not at follow-
up. At follow-up, motivation became significantly associ-
ated with mood (r = .15). The associations between the
other processes were very weak.
Participant 2i-4
Aim 1: treatment effects of switch on motivation and
related processes
At baseline, participant 2i-4, a 39-year-old female, pre-
sented with moderately severe motivational negative
symptoms according to the BNSS, and severe apathy ac-
cording to the LARS-i. At post-measurement, motiv-
ational deficits were evaluated as being mild, and apathy
ratings, accord to the LARS-p, reduced to moderate ap-
athy. Everyday functioning also improved (according to
the participant’s responses on the FROGS), reaching al-
most the threshold for remission. She did not wish to
continue the assessment at follow-up.
The effects on the ESM variables for participant 2i-4
are presented in Table 4. Her ESM data reveal very low
levels of mood (M = 1.79, SD = 1.28) and savouring pro-
cesses (M = 2.20, SD = 1.03). During the intervention
phase, she reported significantly more meaningful activ-
ities (t (df) = 2.36(51); p = .022; d = .55) and significantly
more effortful activities (t (df) = 2.31(62); p = .024; d =
.51). There was a significant intervention effect on
meaningful activities (b = 92; p = .07). Additionally, there
was a significant intervention effect on savouring pro-
cesses (b = .52, p = .09). Finally, her step count increased
significantly (t (df) = 2.71(13); p = .024; d = 1.20) and
there was a significant intervention effect on steps (b =
2270; p = .083). Note that this was based on the data col-
lected during baseline and the first 15 days of the inter-
vention phase, as the step count could not be collected
afterwards due to technical issues.
Based on the pie-charts that are presented in Fig. 8, it
appears that participant 2i-4 experienced more discour-
aging thoughts during the course of the intervention.
However, during the course of the intervention, her use
of coping strategies varied and she started using cogni-
tive restructuring (i.e., using constructive thoughts more
often). Regarding social contact, she appeared to be
alone most of the time, which changed slightly during
the intervention, where she was less alone. Regarding ac-
tivities, participant 2i-4 reported – most of the time –
doing nothing, resting or doing some passive activ-
ities. During the intervention, she reported less pas-
sivity and more activities such as domestic tasks,
leisure and physical activity. Finally, regarding initi-
ation, participant 2i-4 reported more self-initiation
during the intervention phase.
Aim 2: dynamics between motivation and related processes
The network analyses that are presented in Fig. 9 reveal
quite important changes in the dynamics of the various
processes comparing baseline and intervention phases.
At baseline (see Contemporaneous model), we found as-
sociations between savouring processes and mood (r =
.27), confidence and motivation (r = .24), discouraging
thoughts and mood (r = −.15), and weaker associations
between confidence and energy (r = .10), energy and mo-
tivation (r = .09), and discouraging thoughts and savour-
ing (r = −.05). During the intervention (see Intervention,
Contemporaneous model), savouring processes became
more associated with energy (r = .25), discouraging
thoughts (r = −.24) and motivation (r = .09). This indi-
cated that the more she used savouring skills (enjoying
the present moment, looking forward to the future or
reminiscing positively), the less she experienced discour-
aging thoughts, her energy levels increased, and she ex-
perienced more motivation – and vice versa.
Furthermore, there was an increased association between
energy and confidence (r = .19) and energy and motiv-
ation (r = .28), so that, the more she felt confident, the
more she had energy and the more motivated she was.
Moreover, the temporal influence of the different vari-
ables changed substantively (see Temporal models). At
baseline, no variables predicted the other variables at the
next time of measurement. During the intervention
phase, motivation predicted later savouring (r = .19), dis-
couraging thoughts became auto-correlated (r = .32) and
predicted later mood (r = −.26), and confidence became
also auto-correlated (r = .23) and was predicted by previ-
ous levels of energy (r = .12).
Discussion
The aim of this study was to further validate Switch, an
intervention that targets motivation in individuals with
schizophrenia spectrum disorders. We wished to evalu-
ate the effects of Switch on motivation, apathy, quality
of life and daily functioning (primary outcomes), as well
as on daily measures of various processes and outcomes
related to motivation. Furthermore, we aimed to explore
how the processes of interest were interrelated and de-
veloped throughout the course of the intervention, on
an individual level.
The first participant we presented, participant 2i-1, ap-
peared to have benefitted the most from the interven-
tion, showing improvement on both traditional
evaluations of motivation/apathy and functioning, as
well as on processes related to motivation as measured
with the ESM. However, it is not straightforward to in-
terpret her results, as she started relapsing towards the
end of the intervention, potentially because she no lon-
ger adhered to her medication in the period previous to
the start of the intervention. She participated thoroughly
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Fig. 6 Pie charts for nominal variables of participant 2i-2
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Fig. 7 Network models of participant 2i-1. Positive associations appear in green (continuous lines) and negative associations appear in red
(dashed lines). The stronger the relationships, the thicker the edges. Only associations with p-values < .05 are plotted. For a colour version of this
figure, see the digital version of the paper
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Fig. 8 Pie charts for nominal variables of participant 2i-4
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in the intervention, attending all sessions until the 12th
session. She did not come to the last 4 sessions that were
planned and progressively stopped both answering the
ESM questionnaires and using the activity band. How-
ever, she did learn all the strategies that Switch offered
and complied with the homework, as observed during
the sessions. She was present at the booster session
(around 2months after her last session). During both
the booster and feedback sessions, she mentioned that
the strategies she learned in the Switch intervention
allowed her to hold on, which in turn could avert a
“complete crisis” and subsequent hospitalisation. Fur-
thermore, her improvement on savouring processes,
confidence and coping strategies in regard of discour-
aging beliefs points towards a specific effect of Switch.
Finally, the change in the dynamics of the different pro-
cesses is interesting: during and after the intervention,
discouraging thoughts lost their impact on other pro-
cesses (savouring, confidence, energy) related to motiv-
ation and goal-directed behaviours.
Fig. 9 Network models of participant 2i-4. Positive associations appear in green (continuous lines) and negative associations appear in red
(dashed lines). The stronger the relationships, the thicker the edges. Only associations with p-values < .05 are plotted. For a colour version of this
figure, see the digital version of the paper
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Regarding participant 2i-2, Switch had large positive
effects based on the traditional evaluations of motiv-
ation/apathy and QoL/functioning. Surprisingly, these
improvements did not translate into consistent improve-
ments on daily life measures. On the contrary, daily
measures showed that he was feeling slightly less moti-
vated, sadder and experiencing more discouraging
thoughts during the intervention. However, as he ex-
plained at different times (during the intervention and at
the feedback session), feeling sad was an important
change for him. He felt more alive, more sensitive and
reassured that he could still feel emotions despite the
medical treatment. It is possible that the study proced-
ure and the intervention made him more aware of, and
sensitive to, his emotions (see for example [41, 42]).
Nonetheless, we would have hoped for an increase in
positive emotions. Regarding the follow-up evaluation,
we found out after the end of the study (during the feed-
back session) that he stopped taking his medication be-
fore the follow-up assessment, which renders the
interpretation of the follow-up results difficult. Daily
measurements at follow-up revealed that he was more
active and showed more self-initiation, which was not in
line with the results from the traditional evaluations.
Finally, participant 2i-4 also showed improvement based
on the traditional scales. Important to note is that these
results rely solely on her reports, as no informant was in-
volved. This improvement was also perceived in the ESM:
she reported engaging in more activities, which appeared
to be more meaningful and more effortful. Additionally,
her step count increased significantly. However, these im-
provements were not clearly accompanied by changes on
the daily measures of processes related to motivation, ex-
cept for savouring, but only marginally.
Of interest, the network models of each participant reveal
important differences between the participants. On the one
hand, such distinctions might explain the diverse responses
to the intervention. On the other hand, the network models
seem to develop similarly in one way: the interconnected-
ness of the different variables seem to increase over the dif-
ferent phases of the study. Previous studies have
hypothesised that a tightly connected network of symptoms
was associated with higher severity [43]). In our model, we
did not use symptoms, but other psychological variables in-
cluding functional processes. We might thus hypothesize
that an increased connection between those variables is a
sign of better functioning. This would have to be further
explored, comparing samples of healthy individuals with
samples of individuals with different mental disorders.
Overall, while the positive impact of Switch on usual
measures of motivation, apathy and daily functioning was
observed in each participant, this was not consistently
translated by a change in daily life measurements of mo-
tivation and activity, or processes related to motivation
and steps. It is plausible that the impact on certain daily
life processes (i.e., measured with the ESM) develop on a
longer term [44, 45], or that the intervention itself would
need to last longer in order for some cognitive or hedonic
skills to improve for certain individuals. Indeed, the idio-
syncratic analyses revealed very different dynamics be-
tween those processes and it appears that the intervention
impacts each person differently. It is possible that the ef-
fects of Switch depend on baseline symptoms and how
processes interact prior to the intervention. Further devel-
opment of Switch could incorporate these individual dif-
ferences by employing individual network analyses
resulting from the ESM to adapt the intervention to the
person’s more central processes (e.g., [46]). Taking this a
step further, Switch could benefit from an Ecological Mo-
mentary Intervention approach [47], which would help in-
dividuals target the specific difficulties they meet in their
daily lives by making use of a mobile intervention. Finally,
weekly feedback on the ESM measures could also increase
awareness of the measured processes and improve efficacy
in the related skills (e.g., looking forward to the future,
taking distance from discouraging thoughts) (see for ex-
ample [48]).
This study has several strengths, both on a methodo-
logical and a theoretical level. First, we used different
types of instruments to evaluate the effects of our inter-
vention, combining traditional scales (completed by both
participants and informants) and blind evaluations for
our main outcome (BNSS Motivation), daily subjective
reports via online questionnaires (ESM), and daily ob-
jective measurements via step count. Furthermore, this
evaluation procedure was re-applied 3 months later at
follow-up. To the best of our knowledge, this is the first
study to combine an idiographic approach with ESM in
order to explore processes related to motivation during
an intervention for individuals with schizophrenia. Such
an approach enabled an uncovering of the all-important
dynamics and connectedness between variables that
greatly differ from one individual to another, and this
with the help of complex time series analyses. The use
of ESM in clinical trials opens perspectives in the study
of psychopathological phenomena, mediators of change,
and potentially in the development of personalized inter-
ventions and interventions that are closely related to
daily life functioning [19, 20]. Another important
strength of our study is the solid theoretical foundations
of the Switch intervention. Switch was specifically de-
signed to target motivational negative symptoms, but
importantly was based on a multifactorial model of mo-
tivation that encompasses various cognitive, emotional
and behavioural processes.
There are certain limitations worth noting. First, the
study took place in a naturalistic setting, with clear eco-
logical advantages (e.g., generalisability of the findings to
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similar settings), albeit also with some drawbacks such as
lack of control on certain important factors (e.g., change
in medication, relapse). Second, adherence to the assess-
ment protocol was not complete for all participants, thus
limiting certain interpretations. Third, analyses did not
take into consideration the varying lag that spanned be-
tween two observations, which could alter the associations
we found between the variables. To date, analyses that
take into account minutes or hours, rather than the
prompt index (i.e., the prompt number within a day) have
not been developed. Furthermore, the number of observa-
tions per participant may have been too limited to test
more complex models, including for example AR (1)
models with interaction effects. More intensive data would
also allow the use of models able to identify mechanisms
of change (e.g., vector autoregressive moving average
models for multivariate prediction). Finally, the VAR ana-
lyses computed to represent the network models do not
include interaction effects. Therefore, firm inferences
could not be drawn regarding the effects of the interven-
tion on the changes in the dynamical networks.
Conclusions
Switch appears to be beneficial according to traditional
measures of motivation/apathy and quality of life/daily
functioning, and in some cases, regarding processes
measured on a daily basis. The benefits were found in
individuals with different levels (mild to severe) of sever-
ity of motivational negative symptoms and apathy. The
mechanisms of change, however, could not be clearly
identified. It is very plausible that the processes under-
lying the observed improvements vary from one individ-
ual to another. Future studies aiming to validate
interventions for motivational negative symptoms should
investigate the dynamics of processes related to motiv-
ation before and during interventions and, more specif-
ically, aim to reveal these mechanisms of change. Such
an approach would help the refinement of psychological
interventions and guide the focus of those on strategies
that target actual mechanisms of change.
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